NNM Securities

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE7654.80134.9 (+1.79 %)

PREV CLOSE ( ) 7519.90

OPEN PRICE ( ) 7648.45

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1645

TODAY'S LOW / HIGH ( )7531.85 7794.00

52 WK LOW / HIGH ( )1947 7794

NSE7656.35126.65 (+1.68 %)

PREV CLOSE( ) 7529.70

OPEN PRICE ( ) 7550.00

BID PRICE (QTY) 7656.35 (3)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 60734

TODAY'S LOW / HIGH( ) 7530.00 7790.00

52 WK LOW / HIGH ( )1950 7790

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-01 1984

Management Info

Davuluri Rama Mohan Rao - Chairman Davuluri Saharsh Rao - Managing Director

Registered Office

Address 11th Floor (5th Office Level),Phoenix I V Y Building, Plot No.573 A- I I I,Road No. 82, Jubilee Hills,
Hyderabad,
Telangana-500033

Phone 040-67611600 / 67611700

Email neuland@neulandlabs.com

Website www.neulandlabs.com

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, MCX

NEWS

03Apr Neuland Laboratories informs about cer
Neuland Laboratories has informed that it enclosed certificate as requir..

04Mar Neuland Laboratories informs about ana
Neuland Laboratories has informed that the Company’s management will be..

26Feb Neuland Laboratories informs about iss
Pursuant to the Regulation 39(3) of the SEBI (Listing Obligations and Di..

13Nov Neuland Laboratories informs about tra
Neuland Laboratories has informed that it enclosed the transcript of the..

Financials

Rs. in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	807.01	1631.19
Gross Profit	1037.8	2152.13
Operating Profit	1226.65	2810.56
Net Sales	3928.28	11911.98

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

NGL Fine-Chem (BSE) 2542.60 (12.29%)	M.Cap (Rs. in Cr)1570.82
Mankind Pharma (BSE) 2397.40 (5.05%)	M.Cap (Rs. in Cr)96037.07
Sanofi India (BSE) 8470.70 (0.89%)	M.Cap (Rs. in Cr)19508.55
Solara Active Pharma (BSE) 474.10 (12.15%)	M.Cap (Rs. in Cr)1706.58
Concord Biotech (BSE) 1578.65 (3.10%)	M.Cap (Rs. in Cr)16515.24

Shareholding Pattern

	NON-INSTITUTION	35.88%
	PROMOTERS	32.74%
	MUTUAL FUNDS/UTI	3.88%
	GOVERNMENT	0.4%
	FI/BANKS/INSURANCE	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
Motilal Oswal Nifty...	1.00
Bandhan Small Cap F...	0.74
WOC ELSS Tax Saver ...	0.70
WOC Multi Cap Fund-Reg(G)	0.68
WOC Flexi Cap Fund-Reg(G)	0.60
Motilal Oswal S&P B...	0.52
WOC Mid Cap Fund-Reg(G)	0.51

ATTENTION INVESTORSKYCIPO

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :

Assamese	Bengali	Gujrati	Hindi	Kanada
Kashmiri	Konkani	Malyalam	Marathi	Oriya
Punjabi	Sindhi	Tamil	Telegu	Urdu

REGISTRATION NOS.

Filing compliant on SCORES – Easy & quick

Register on SCORES portal
Mandatory details for filing complaints on SCORES:
- Name
- PAN
- Address
- Mobile Number
- E-mail ID
Benefits:
- i.) Effective communication
- ii.) Speedy redressal of the grievances

SMART ODR Portal

INVESTOR PROTECTION

Compliance officer : Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075, E-mail ID: compliance@nnmsecurities.com, cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

"NNM Securities has partnered with TradingView for its charting technology. An investment and trading platform empowering users with global market data and analytical tools like Stock Screener and Economic Calendar."

Advanced Charts Technology Partner: TradingView

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

NNM Securities

Smart Quotes

NEULAND LABORATORIES LTD.

Filing compliant on SCORES – Easy & quick